A new year always brings new challenges, and there will be many of them facing the pharmaceutical industry and policymakers ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

Like other developing countries, Indonesia is facing a familiar dilemma: how to feed a growing population while protecting ...

French engineer-virologist Thomas Mollet examines cells infected with a Sars-CoV-2 virus at the Biosafety level 3 laboratory in Saint-Herblain, France. Jean-Francois Monier/AFP via Getty Images ...

Every biotech lab in the world leaks money in a silent way. Through lost time. Not broken equipment or failed experiments, but from something far less visible: information that exists somewhere in the ...

The European Commission is concerned that diverging policies in member states could derail the European Union's Strategy for Life Sciences and Biotechnology. The concern is expressed in the Commission ...

Hemogenyx Pharmaceuticals now knows what it will take to lift the clinical hold on its CAR-T cell therapy candidate. In its full review letter, the FDA cited a manufacturing issue as the cause of the ...

LONDON (Reuters) - Biotech stocks advanced in Europe on Monday as the failure of Pfizer Inc's experimental drug torcetrapib highlighted pipeline problems at big pharma firms, which are expected to ...

Uncertainty surrounds the future of an economic development project once touted by Orangeburg County officials as "huge" and "significant" to boosting the county's industrial and agricultural climate.

Peanut allergies, which affect 3 million U.S. residents and kill approximately 150 U.S. residents every year, may soon be a thing of the past, thanks to biotechnology. Writing in the May 3 issue of ...